The store will not work correctly when cookies are disabled.
US9011882, Table 1, Compound 18
ID: ALA3677847
PubChem CID: 20877230
Max Phase: Preclinical
Molecular Formula: C13H17N3O3S
Molecular Weight: 295.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCCNC(=O)Cn1sc2nc(C)cc(C)c2c1=O
Standard InChI: InChI=1S/C13H17N3O3S/c1-8-6-9(2)15-12-11(8)13(18)16(20-12)7-10(17)14-4-5-19-3/h6H,4-5,7H2,1-3H3,(H,14,17)
Standard InChI Key: DDGDTEDJJKQMCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
9.1659 -8.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5637 -7.0091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0629 -7.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3098 -5.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8090 -5.7153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0559 -4.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6540 -3.3768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5551 -4.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4916 -3.8582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 15 2 0
15 16 1 0
16 17 1 0
16 18 2 0
18 11 1 0
18 19 1 0
19 9 1 0
19 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.36 | Molecular Weight (Monoisotopic): 295.0991 | AlogP: 0.84 | #Rotatable Bonds: 5 |
Polar Surface Area: 73.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.24 | CX LogP: 0.45 | CX LogD: 0.45 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.83 | Np Likeness Score: -1.55 |
References
1. (2015) Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof, |
2. (2014) Dimethylarginine Dimethylaminohydrolase inhibitors and methods of use thereof, |